Wealth Enhancement Advisory Services
MAIA icon

Wealth Enhancement Advisory Services’s MAIA Biotechnology MAIA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Hold
14,800
– – ﹤0.01% 4028
2026
Q1 		$19.7K Hold
14,800
– – ﹤0.01% 3505
2025
Q4 		$22.6K Hold
14,800
– – ﹤0.01% 3578
2025
Q3 		$26.5K Hold
14,800
– – ﹤0.01% 3489
2025
Q2 		$27.4K Hold
14,800
– – ﹤0.01% 3276
2025
Q1 		$22.6K Hold
14,800
– – ﹤0.01% 2909
2024
Q4 		$29.3K Hold
14,800
– – ﹤0.01% 2891
2024
Q3 		$41.6K Hold
14,800
– – ﹤0.01% 2633
2024
Q2 		$50.6K Sell
14,800
-1,200
-8% -$3.78K ﹤0.01% 2454
2024
Q1 		$35.2K Buy
16,000
+1,200
+8% +$1.8K ﹤0.01% 2360
2023
Q4 		$17.3K Buy
+14,800
New +$23.9K ﹤0.01% 2264

Other funds holding MAIA

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
CAG
Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return

Wealth Enhancement Advisory Services's MAIA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services held its MAIA Biotechnology (MAIA) position steady in Q2 2026 at 14,800 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4028.

Wealth Enhancement Advisory Services first reported a position in MAIA in Q4 2023 and has held it in 11 quarters since. The position peaked at $50.6K in Q2 2024. 5 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Wealth Enhancement Advisory Services held 14,800 shares of MAIA Biotechnology worth $21.3K as of Q2 2026.
  • Wealth Enhancement Advisory Services left its MAIA Biotechnology share count unchanged in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #4028 holding.
  • Wealth Enhancement Advisory Services first reported a position in MAIA Biotechnology in Q4 2023 and has held it in 11 quarters since.
  • Wealth Enhancement Advisory Services's MAIA Biotechnology position peaked at $50.6K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.